7 completed, 3 unknown, 1 not yet recruiting, 1 terminated. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 7, Unknown 3, Not yet recruiting 1, Terminated 1 |
Follow Caspofungin: new trials by email Literature Review of Caspofungin trials Research Report on Caspofungin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial Caspofungin only within the study, Caspofungin for 3 days within the study, Placebo only within the study - Candidemia, Invasive Candidiasis | Phase 4 | Not yet recruiting | Oliver Cornely, MD | 420 | 2026-09-01 | 2026-09-01 |
| To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation Micafungin Sodium 50 MG Injection, Caspofungin Acetate - Liver Transplantation | Phase 4 | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 200 | 2022-10-01 | 2022-08-16 |
| Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP caspofungin, TMP/SMZ(trimethoprim/sulfisoxazole), Methylprednisolone - Pneumocystis Pneumonia | Phase 4 | Unknown | Bin Du | 122 | 2019-08-14 | 2019-09-12 |
| Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study) Echinocandins - Septic Shock, Peritonitis | Phase 4 | Completed | Centre Hospitalier Universitaire de Nīmes | 24 | 2017-01-28 | 2025-12-10 |
| A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy Itraconazole, Caspofungin - Hematologic Neoplasms | Phase 4 | Terminated | Xian-Janssen Pharmaceutical Ltd. | 61 | 2016-11-30 | 2019-05-06 |
| Optimal Dosage of Caspofungin in Critically Ill Patients Caspofungin - Critically Ill, Suspected Invasive Candidiasis | Phase 4 | Completed | University Medical Center Groningen | 20 | 2013-11-01 | 2015-10-30 |
| Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure Caspofungin 70 mg - Bacterial Infections and Mycoses, Liver Disease | Phase 4 | Completed | Erasme University Hospital | 20 | 2013-09-01 | 2019-02-15 |
| Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease caspofungin - Invasive Pulmonary Aspergillosis, Chronic Obstructive Pulmonary Disease | Phase 4 | Unknown | The First Affiliated Hospital of Guangzhou Medical University | 40 | 2012-01-01 | 2014-01-23 |
| Effect of Weight and/or Obesity on Caspofungin Drug Concentrations Caspofungin - Obesity, Fungal Infection | Phase 4 | Completed | Texas Tech University Health Sciences Center | 18 | 2010-02-01 | 2017-02-10 |
| Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins micafungin, Micafungin, Caspofungin - Candidemia | Phase 4 | Completed | Gary E. Stein, Pharm.D. | 21 | 2008-12-01 | 2024-04-30 |
| Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Caspofungin, Normal Saline - Invasive Candidiasis | Phase 4 | Completed | Mycoses Study Group | 222 | 2007-08-01 | 2011-05-09 |
| COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis Ambisome, caspofungin - Invasive Aspergillosis | Phase 4 | Completed | Gilead Sciences | 30 | 2004-03-01 | 2015-07-09 |
Candidemia (2) · Candidiasis, Invasive (2) · Bacterial Infections and Mycoses (1) · Critical Illness (1) · Hematologic Neoplasms (1) · Invasive Fungal Infections (1) · Invasive Pulmonary Aspergillosis (1) · Liver Diseases (1) · Mycoses (1) · Obesity (1) · Peritonitis (1) · Pneumonia, Pneumocystis (1) · Pulmonary Disease, Chronic Obstructive (1) · Shock, Septic (1) · Torulopsis (1)
Bin Du (1) · Centre Hospitalier Universitaire de Nīmes (1) · Erasme University Hospital (1) · Gary E. Stein, Pharm.D. (1) · Gilead Sciences (1) · Mycoses Study Group (1) · Oliver Cornely, MD (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · Texas Tech University Health Sciences Center (1) · The First Affiliated Hospital of Guangzhou Medical University (1) · University Medical Center Groningen (1) · Xian-Janssen Pharmaceutical Ltd. (1)
China (3) · United States (3) · France (2) · Australia (1) · Belgium (1) · Germany (1) · Netherlands (1)
Claire Roger, MD (1) · Feng Ye, MD (1) · Gary E Stein, Pharm.D. (1) · Jan-Willem Alffenaar, PharmD, PhD (1) · Lamine Mahi, MD (1) · Luis Ostrosky-Zeichner, MD (1) · Peter G Pappas, MD (1) · Ronald Hall, PharmD, MSCS (1)
PMID 23459494, PMID 24550378, PMID 27855112, PMID 29860319, PMID 33846133
2016 (1), 5UL1RR024982-02 (1)